MagIA Diagnostics develops innovative immunoassay solutions for both biopharmaceutical development and point-of-care diagnostics. Their MforLab system provides an at-line immunoassay platform that enables real-time monitoring of active ingredients such as viruses, vaccines, recombinant proteins, and antibodies during upstream and downstream bioprocess development, helping teams optimise conditions and reduce reliance on traditional ELISA testing. For clinical applications, the MforScreen analyser offers a portable point-of-care solution for rapid STI screening from a single finger-prick blood sample, delivering reliable results in around 12 minutes through a simple cartridge-based testing workflow.